Association of annual volume and in-hospital outcomes of catheter-directed thrombolysis for pulmonary embolism

Catheter Cardiovasc Interv. 2022 Feb;99(2):440-446. doi: 10.1002/ccd.30080. Epub 2022 Jan 27.

Abstract

Objective: We sought to evaluate the association between the institutional volume of catheter-directed thrombolysis (CDT) for pulmonary embolism and in-hospital mortality.

Background: CDT is an increasingly utilized therapy in patients with intermediate/high-risk PE. However, data on the relationship between hospital volume and clinical outcomes remain limited.

Methods: Patients who underwent CDT between October 1, 2015, and March 31, 2021, were identified in the Vizient Clinical Database. The primary outcome was in-hospital mortality. Secondary outcome were major complications, length of stay, and cost. Hospitals were dichotomized into <8 and 8 cases/year following restricted cubic spline analysis.

Results: A total of 6741 CDT procedures at 171 hospitals were included with a median annual hospital volume of 4.1 cases (IQR = 1.9-8.3). A total of 44 hospitals (25.7%) were classified as high-volume ( 8 cases/year) and performed 60.9% of all CDT cases. CDT at high-volume centers was associated with lower in-hospital mortality (6.0% vs. 11.3%; p < 0.0001). Stroke and bleeding rates were similar, but pulmonary complications were more frequent at low-volume centers. CDT at high volume centers was associated with a significantly shorter length of stay and lower cost. The association between high CDT volume and in-hospital mortality persisted after adjustment for demographics (odds ratio [OR] = 0.49, [0.41-0.58]), demographics and risk factors (OR = 0.52 [0.44-0.62]), and demographics, risk factors, and troponin elevation (OR = 0.51 [0.40-0.66]).

Conclusion: In a large contemporary cohort of patients undergoing CDT in the United States, low annual institutional volume of CDT was associated with higher in-hospital mortality.

Keywords: peripheral intervention; pulmonary embolism; thrombolytic therapy.

MeSH terms

  • Catheters
  • Fibrinolytic Agents / adverse effects
  • Hospitals
  • Humans
  • Pulmonary Embolism* / drug therapy
  • Pulmonary Embolism* / therapy
  • Retrospective Studies
  • Thrombolytic Therapy* / methods
  • Time Factors
  • Treatment Outcome
  • United States

Substances

  • Fibrinolytic Agents